Clinical Trials Browser

Interventional × Has results × tanespimycin × Clear all

NCT01228435 2017-12-04

IPI-504 in NSCLC Patients With ALK Translocations

Phase 2 Terminated

3 enrolled 5 charts

Lung Neoplasms

NCT00118092 2017-04-18

17-AAG in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy

Phase 2 Completed

17 enrolled 6 charts

Prostatic Neoplasms

NCT00118248 2017-02-15

Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer

Phase 2 Completed

41 enrolled 10 charts

EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary

NCT00096109 2017-01-16

Tanespimycin in Treating Women With Refractory Locally Advanced or Metastatic Breast Cancer

Phase 2 Terminated

11 enrolled 6 charts

Breast Neoplasms

NCT00577889 2014-07-25

Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Stage IV Pancreatic Cancer

Phase 2 Completed

21 enrolled 9 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00117988 2014-05-30

17-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin's Lymphoma

Phase 2 Completed

22 enrolled 5 charts

Hodgkin Disease, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Mantle-Cell

NCT00093496 2014-05-20

Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer

Phase 2 Completed

29 enrolled 9 charts

Carcinoma, Ovarian Epithelial

NCT00088374 2012-07-27

17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease

Phase 2 Completed

9 enrolled 8 charts

Carcinoma, Renal Cell, von Hippel-Lindau Disease, Kidney Neoplasms